Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...

The once-daily pill combines Opko’s long-acting GLP-1/glucagon dual agonist peptide, dubbed OPK-88006, with Entera’s N-Tab ...

Danish company Novo Nordisk's membership in a UK pharmaceutical industry body has been restored after a two-year suspension ...

“Whether consumers are using GLP-1 medications for weight management or are reducing sugar intake as part of their overall ...

A report by a U.N. committee found that Israel has committed “genocidal acts” intended to prevent births. Israel quickly rejected the findings as biased. By Nick Cumming-Bruce Reporting from ...

Medications like Mounjaro and Wegovy have been hailed as "game changers" for tackling obesity. These injections suppress people's appetites, causing them to feel fuller sooner - but they are not ...

ABC News' Dr. Tara Narula shares what patients need to know. Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U ...

(Reuters) -OPKO Health and Entera Bio are partnering to develop a once-daily pill for patients with obesity and other ...

The second cycle of negotiations will take place under President Donald Trump's administration. The U.S. government has said ...

An astonishing 87% of young Jews who visited Israel in 2024 did so through Birthright Israel. This statistic underscores the program’s enduring significance and transformative impact ...

The United States has put forward a new proposal that would secure the release of a handful of living hostages held by Hamas in exchange for a month-long extension of the Israel-Hamas ceasefire ...

The Trump administration aims to overhaul publicly funded science. Critics say cuts could undermine U.S. leadership that has ...